Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12084453 Bicyclic amines as CDK12 inhibitors

Patent 12084453 was granted and assigned to Incyte on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Oleg Vechorkin0

Xin Li0

Hai Fen Ye0

Minh Nguyen0

Date of Patent

September 10, 2024

0

Patent Application Number

180641730

Date Filed

December 9, 2022

0

Patent Citations

US Patent 8168757 PD-1 binding proteins

0

US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture

0

US Patent 9828373 2-amino-pyrido[2,3-D]pyrimidin-7(8H)-one derivatives as CDK inhibitors and uses thereof

0

US Patent 9670202 Substituted triazolopyridines

0

US Patent 10059690 Inhibitors of cyclin-dependent kinase 7 (CDK7)

0

US Patent 10106526 Inhibitors of cyclin-dependent kinase 7 (CDK7)

0

US Patent 10111875 Pyrrolopyrimidine compounds and uses thereof

0

US Patent 10519135 Inhibitors of cyclin-dependent kinase 7 (CDK7)

0

...

Patent Primary Examiner

Joseph R Kosack

0

Patent abstract

The present application provides bicyclic amines that are inhibitors of cyclin-dependent kinase 12 (CDK12), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12084453 Bicyclic amines as CDK12 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool